IMMUNISATIONS FOR ADULTS
Diphtheria / Tetanus / Polio
In accordance with Government guidelines, adults should receive the Diphtheria, Tetanus and Polio Booster at age 15 - and every 10 years thereafter - if exposed to risks due to travel or working environment.
In accordance with Government guidelines, adults should receive the Diphtheria, Tetanus and Polio Booster at age 15 - and every 10 years thereafter - if exposed to risks due to travel or working environment.
Influenza
Flu vaccine is especially recommended for all aged 65 years and over - and those patients with chronic conditions such as Asthma, Diabetes, Heart Disease and Liver Disease.
Please ask at Reception if you are uncertain whether you are eligible.
Flu vaccine is especially recommended for all aged 65 years and over - and those patients with chronic conditions such as Asthma, Diabetes, Heart Disease and Liver Disease.
Please ask at Reception if you are uncertain whether you are eligible.
Pneumonia
One injection of Pneumovax will give you virtually life-long immunisation against Pneumonia caused by bacteria called Streptococcus Pneumoniae (except in Splenectomy patients who need further injections).
This is recommended for all patients aged 65 years and over - and to those with chronic conditions such as Asthma, Diabetes and Heart Disease.
One injection of Pneumovax will give you virtually life-long immunisation against Pneumonia caused by bacteria called Streptococcus Pneumoniae (except in Splenectomy patients who need further injections).
This is recommended for all patients aged 65 years and over - and to those with chronic conditions such as Asthma, Diabetes and Heart Disease.
Shingles
The vaccine against the varicella-zoster virus has been shown in large studies to be effective in reducing the risk of older people developing shingles. The vaccine has been shown to be safe with very few side-effects.
In the UK, there is a shingles vaccination programme for people aged 70 and 79. The programme began in September 2013.
The vaccine against the varicella-zoster virus has been shown in large studies to be effective in reducing the risk of older people developing shingles. The vaccine has been shown to be safe with very few side-effects.
In the UK, there is a shingles vaccination programme for people aged 70 and 79. The programme began in September 2013.
